Early Relapse within 24 Months after Frontline Systemic Therapy (POD24) Is Associated with Worse Survival in Patients with Marginal Zone Lymphoma: A US Multisite Study

Saved in:
Bibliographic Details
Published in:Blood 2022-11, Vol.140 (Supplement 1), p.1926-1928
Main Authors: Epperla, Narendranath, Li, Rui, Torka, Pallawi, Shea, Lauren, Karmali, Reem, Anampa-Guzman, Andrea, Seijung Oh, Timothy, Lindsey, Kathryn, Greenwell, Irl Brian, Chowdhury, Sayan Mullick, Annunzio, Kaitlin, Christian, Beth, Shouse, Geoffrey, Herrera, Alex F., Bartlett, Nancy L., Grover, Natalie S., Olszewski, Adam J.
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0006-4971
1528-0020
DOI:10.1182/blood-2022-166785